CF Tummy Tracker: A Cystic Fibrosis-Specific Patient-Reported Outcome Measure for Daily Gastrointestinal Symptom
Rebecca J Calthorpe1, Hisham A Saumtally2, Laura M Howells3
1School of Medicine and NIHR Nottingham Biomedical Research Centre, Nottingham, United Kingdom.
A new tool, the CF Tummy Tracker, measures daily gastrointestinal symptom burden in people with cystic fibrosis (pwCF). This validated patient-reported outcome measure (PROM) addresses a critical need for CF gastrointestinal symptom assessment.
Area of Science:
- Gastroenterology
- Pulmonology
- Medical Device Development
Background:
- Gastrointestinal (GI) symptoms significantly impact the quality of life for individuals with cystic fibrosis (CF).
- A lack of validated, CF-specific patient-reported outcome measures (PROMs) for daily GI symptom burden hinders effective clinical management and research.
- Existing outcome measures do not adequately capture the daily nuances of GI distress experienced by people with CF (pwCF).
Purpose of the Study:
- To develop and validate a novel, CF-specific PROM designed for daily assessment of gastrointestinal symptom burden.
- To address the unmet need for a reliable tool to measure the daily impact of GI symptoms in pwCF aged 12 and older.
- To create a patient-centered outcome measure that can be easily integrated into clinical practice and research.
Main Methods:
- A 5-stage development process adhering to regulatory guidance, including conceptual framework development, item generation, refinement, reduction, and initial testing.
- A mixed-methods approach incorporating expert panels, focus groups (n=7 pwCF), interviews (n=11 pwCF), and an online survey (n=180 pwCF) for comprehensive input.
- Initial validation involved 151 pwCF completing the CF Tummy Tracker daily for 14 days via a smartphone application.
Main Results:
- The CF Tummy Tracker, a 10-item PROM, was developed with significant input from the CF community.
- The PROM demonstrated no floor or ceiling effects, indicating a comprehensive measurement range.
- High test-retest reliability (ICC=0.94) and strong correlation with an anchor question confirm the PROM's stability and validity.
Conclusions:
- The CF Tummy Tracker effectively addresses the gap for a validated, CF-specific PROM for daily GI symptom assessment.
- Further psychometric validation in a new patient cohort is planned to support its use in clinical trials.
- The PROM is intended for use in both electronic and paper formats to enhance accessibility for pwCF.
More Related Videos
Related Concept Videos
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Cystic Fibrosis: Management
Sinus disease and chronic...
Assessment of the Gastrointestinal System II: Health Perception Pattern
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...


